Cargando…
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia
Treatment of chronic illness accounts for over 90 % of Medicare spending. Chronic lymphedema places over 3 million Americans at risk of recurrent cellulitis. Health insurers and legislators have taken an active role in fighting attempts to mandate the treatment of lymphedema for fear that provision...
Autor principal: | Weiss, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010541/ https://www.ncbi.nlm.nih.gov/pubmed/27590738 http://dx.doi.org/10.1186/s13561-016-0117-3 |
Ejemplares similares
-
Erratum to: Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia
por: Weiss, Robert
Publicado: (2016) -
Cost of a lymphedema treatment mandate - 16 years of experience in the Commonwealth of Virginia
por: Weiss, Robert
Publicado: (2022) -
Estimating Workforce-Related Economic Impact of a Pandemic on the Commonwealth of Virginia
por: Orsi, Mark J., et al.
Publicado: (2009) -
Practice Forum: A new section led by the Center for Pharmacy Practice Innovation at Virginia Commonwealth University School of Pharmacy
por: Salgado, Teresa M., et al.
Publicado: (2019) -
The Commonwealth Caribbean : the integration experience : report of a mission sent to the Commonwealth Caribbean by the World Bank /
por: Chernick, Sidney E.
Publicado: (1978)